Current Protocols webinar: The Race Is On: Faster Turnaround Times in the Diagnosis of Multidrug-Resistant Tuberculosis

 

 

In 2014, the Centers for Disease Control reported 9,412 new cases of tuberculosis (TB). TB elimination is defined as 1 case per million population and with an estimated population in the United States (July 2014) of almost 319 million, this would result in only 319 cases – we have a long way to go in order to reach this ambitious goal. In this webinar, Dr. Max Salfinger (National Jewish Health in Denver, Colorado) will provide an overview of the TB epidemic in the United States and abroad as well as the various molecular laboratory assays used to diagnose TB. Each laboratory plays an integral role in an overarching system comprised of health care providers, the laboratory community (hospital, commercial, public health and reference laboratories) and TB control. Dr. Salfinger will answer questions from webinar attendees so be sure to come prepared with your questions! Register Now Event Details Thursday, Dec. 10 11:00 AM - 12:00 PM EST 8:00 AM - 9:00 AM PST 4:00 PM - 5:00 PM GMT 5:00 PM - 6:00 PM CET In China: Friday, Dec. 11 1:00 AM China Standard Time Friday, Dec. 11 9:00 AM - 10:00 AM China Standard Time 1:00 AM - 2:00 AM GMT 2:00 AM - 3:00 AM CET In the US: Thursday, Dec. 10 5:00 PM - 6:00 PM PST 8:00 PM - 9:00 PM EST

What you will learn: An overview of the TB epidemic in the United States and abroad An understanding of the most important assays performed in TB research laboratories An understanding of the important role the laboratory plays in diagnosing TB Who should attend: Healthcare professionals (doctors, pharmacists, nurses) Microbiology laboratory personnel, decision makers with regard to antimicrobial prescribing, patient safety and risk management staff Those working within infection prevention and control Register Now

About the presenter:

Max Salfinger, M.D. is currently the Director of the Mycobacteriology and Pharmacokinetics Laboratories at National Jewish Health in Denver, Colorado, and is a Fellow of the Infectious Disease Society of America (FIDSA) and the American Academy of Microbiology (FAAM). Before joining National Jewish Health, he was the Florida State Public Health Laboratory Director from 2006-2012, as well as the Acting Florida State TB Controller for his last 19 months with the Florida Department of Health. Prior to his Florida position, Dr. Salfinger was with the New York State Department of Health Wadsworth Center from 1992 to 2006.

 

About the moderator:

Dr. Gwen Taylor is the Senior Developmental Editor and Webinar Program Manager for Current Protocols, Wiley publishers.

 

Register Now